Rice University has again topped a list of the best schools in the country. Photo courtesy of Rice University

Houston's Rice University continues to burnish its reputation in higher education.

A ranking released May 5 by QS Quacquarelli Symonds, a British company that specializes in higher education data, puts Rice at No. 23 among the top colleges and universities in the U.S. It's the highest-rated Texas school on the list.

Harvard University appears at No. 1 in the ranking, followed by Stanford University; the Massachusetts Institute of Technology (MIT); the University of California, Berkeley; and the University of California, Los Angeles (UCLA).

Elsewhere in Texas:

  • The University of Texas at Austin ranks 29th.
  • Texas A&M University in College Station ranks 64th.
  • The University of Houston ranks 66th.
  • The University of Texas at Dallas ranks 83rd.

To come up with its ranking, QS Quacquarelli Symonds looked at five factors for more than 350 colleges and universities around the country: employability, learning experience, diversity and internationalization, and research.

Here's how Rice fares in each of those categories:

  • Employability, No. 42.
  • Learning experience, No. 7.
  • Diversity and internationalization, tied for No. 32.
  • Research, No. 33.

Jack Moran, a spokesman for QS Quacquarelli Symonds, says that although the rankings "continue to command record levels of interest, we know that the American higher education sector is wrestling with questions that do not fall within the scope of our … rankings — questions of equity, access, representation, and social justice."

"The QS USA University Rankings have been carefully crafted to shine some independent light on which institutions are doing most to foster the essential relationship between education and social change," Moran adds.

More students soon will be able to take advantage of the top-rated education offered by Rice. In March, the private university announced it would expand the number of undergraduates by 20 percent by the fall of 2025. This would raise undergraduate enrollment to 4,800 and total enrollment to about 9,000.

"Rice's extraordinary applicant pool has grown dramatically despite the challenges posed by the pandemic," President David Leebron says in a news release.

Rice says the number of student applications has climbed 75 percent over the past four years. In 2020, the university received roughly 28 applications for every available slot. For the fall of 2021, almost 30,000 applicants flooded Rice, up 26 percent from the previous year.

Leebron says Rice's previous expansion of enrollment "greatly increased our national and international student applications, enrollment, and visibility. We also dramatically increased diversity on our campus, and we were able to extend the benefits of a Rice education to many more students."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.